Get Premium to unlock powerful stock data
NAS:GTHX (USA)  
G1 Therapeutics Inc logo

G1 Therapeutics Inc

$ 5.54 +0.24 (+4.53%) 10:08 PM EST
P/E:
At Loss
P/B:
2.36
Market Cap:
$ 236.59M
Enterprise V:
$ 135.69M
Volume:
5.23M
Avg Vol (2M):
1.32M
Also Trade In:
Volume:
5.23M
Market Cap $:
236.59M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.32M
Enterprise Value $:
135.69M
PB Ratio:
2.36
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

G1 Therapeutics Inc
NAICS : 325412 SIC : 2834
700 Park Offices Drive, Suite 200, Research Triangle Park, NC, USA, 27709
Description
G1 Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat most types of cancer such as cell lung cancer and breast cancer and designs them to combine - and enhance - the anti-tumor activity of current therapies.
Name Current Vs Industry Vs History
Cash-To-Debt 2.23
Equity-to-Asset 0.46
Debt-to-Equity 0.82
Debt-to-EBITDA -0.5
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.28
Distress
Grey
Safe
Beneish M-Score -1.82
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 86.22
9-Day RSI 71.31
14-Day RSI 61.34
6-1 Month Momentum % -58.67
12-1 Month Momentum % -79.93

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.96
Quick Ratio 5.73
Cash Ratio 5.23
Days Inventory 464.4
Days Sales Outstanding 86.27
Days Payable 774.63

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4.6

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 89.89
Operating Margin % -677.58
Net Margin % -708.2
ROE % -97.15
ROA % -65.75
ROIC % -1053.8
ROC (Joel Greenblatt) % -1743.48
ROCE % -70.72

Financials (Next Earnings Date:2022-08-04 Est.)

GTHX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:GTHX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 24.16
EPS (TTM) ($) -4.03
Beta 2
Volatility % 44.97
14-Day RSI 61.34
14-Day ATR ($) 0.448289
20-Day SMA ($) 4.6615
12-1 Month Momentum % -79.93
52-Week Range ($) 3.84 - 24.12
Shares Outstanding (Mil) 42.71

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

G1 Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More